最新报道:According to the Bijie.com news, Nasdaq-listed biotechnology company Equillium announced the launch of a cryptocurrency reserve strategy, integrating the cryptocurrency fund reserve strategy into its broader financial and growth goals. The company's total cash and cash equivalents as of June 30, 2025 were approximately US$11.5 million, and it has not yet disclosed which digital currencies it will purchase.